Looks like trial has been put back until March 2011. Hopefully this will help CC patients in the future.
Trial Name (Short): ABC-03 Trial Name: Randomised phase II trial of cediranib (AZD2171) vs. placebo in addition to cisplatin / gemcitabine chemotherapy for patients with advanced biliary tract cancer Description: This phase II trial builds on the ABC-02 trial in which patients were randomised to gemcitabine alone or gemcitabine plus cisplatin (CisGem). The CisGem arm showed a 3.5 month survival advantage and a 2 month progression free survival advantage.
In ABC-03, the aim will be to see if adding cediranib to CisGem will be more effective than CisGem alone. Cediranib is an unlicensed VEGF inhibitor. This trial is part of the NCRN/AstraZeneca collaboration
Trial Status: In set-up
Trial Coordinator: Elka Humphrys Email Contact: Email Trial Summary: Opening Date: 01/03/2011 (Estimated)
Recruitment Target: 136 Funder: CRUK & AstraZeneca
Chief Investigator: Dr Juan Valle
Page last updated on 11/01/2011 by Colin Lunt
Devoted Daughter to the most wonderful Dad a girl could ask for. Sadly lost his battle on 19.02.11, peacefully in the arms of Mom and I. As requested by Dad "we will keep on smiling".